Evaluation of <sup>161</sup>Tb-Labeled Diphosphonates as Potential Bone-Targeting Agents. [PDF]
Sitarica P +9 more
europepmc +1 more source
Zoledronic acid for chronic kidney disease-associated osteoporosis. [PDF]
Sakthivel S +4 more
europepmc +1 more source
Bisphosphonate Use in Acute Spinal Cord Injury: A Focused Systematic Review on Zoledronic Acid. [PDF]
Mun S +5 more
europepmc +1 more source
Knowledge of Iranian Dentists about Osteonecrosis of the Jaw due to the Use of Bisphosphonate Drugs
Objective: To evaluate the knowledge of Iranian dentists regarding bisphosphonate-related osteonecrosis of the jaw (BRONJ) etiology, risk assessment, and clinical management, aiming to identify gaps in knowledge and inform targeted educational ...
Zahra Atai +4 more
doaj
Clinical Efficacy and Safety of Teriparatide Versus Alendronate in Postmenopausal Osteoporosis: A Systematic Review of Randomized Controlled Trials. [PDF]
Nunkoo S +5 more
europepmc +1 more source
THE USE OF DIPHOSPHONATES IN MYELOMA [PDF]
J A, Kanis, A D, Paterson, R G, Russell
openaire +2 more sources
Non-union after bisphosphonate-associated atypical femoral fractures: a review of the current literature. [PDF]
Dowling J, Marsh S, O'Grady J.
europepmc +1 more source
The impact of DXA findings on general practitioners' decision regarding first-line oral bisphosphonates in postmenopausal osteoporosis-data from French General Practice (the IMOGENE study). [PDF]
Cortet B +4 more
europepmc +1 more source
Risk factors for skeletal-related events in patients with stage IV lung adenocarcinoma and bone metastases receiving denosumab: a retrospective cohort analysis. [PDF]
Zhang H +6 more
europepmc +1 more source
Anterior uveitis and diffuse scleritis after pamidronate infusion. [PDF]
Xie JS, Kaplan AJ.
europepmc +1 more source

